CD109 and pancreatic ductal adenocarcinoma: Although the loss of CD109 in pancreatic ductal adenocarcinoma and cervical squamous cell carcinoma suppressed in vivo tumor growth [27,28], knockdown in A2780-R cells had no significant effect on transplanted tumor growth through cell proliferation (Figure 4 and Figure S5).